Curis
CRIS
#10633
Rank
A$18.16 M
Marketcap
A$0.47
Share price
55.98%
Change (1 day)
-86.88%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.33. In 2024 the company made an earnings per share (EPS) of A-$10.21 an increase over its 2023 EPS that were of A-$13.11.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-43.3%
2024A-$10.21-22.15%
2023A-$13.11-26.17%
2022A-$17.7622.3%
2021A-$14.52-25.37%
2020A-$19.45-30.93%
2019A-$28.16-2.02%
2018A-$28.75
2016A-$65.33-10%
2015A-$72.59138.1%
2014A-$30.4940%
2013A-$21.78-25%
2012A-$29.0466.67%
2011A-$17.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.90-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$5.17-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.52-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.54-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.65 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$16.32 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.05-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA